A Dynamic Model for Estimating the Retention Duration of Neutralizing Antibody Titers After Vaccination in a COVID-19 Convalescent Population

J Infect Dis. 2024 Feb 14;229(2):398-402. doi: 10.1093/infdis/jiad431.

Abstract

We measured neutralizing antibodies (nAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a cohort of 235 convalescent patients (representing 384 analytic samples). They were followed for up to 588 days after the first report of onset in Taiwan. A proposed Bayesian approach was used to estimate nAb dynamics in patients postvaccination. This model revealed that the titer reached its peak (1819.70 IU/mL) by 161 days postvaccination and decreased to 154.18 IU/mL by day 360. Thus, the nAb titers declined in 6 months after vaccination. Protection, against variant B.1.1.529 (ie, Omicron) may only occur during the peak period.

Keywords: Bayesian; COVID-19; Markov chain Monte Carlo; neutralizing antibody titer.

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Bayes Theorem
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral